ストックスクリーナーアプリを入手
31.44
4.96%
-1.64
アフターアワーズ：
31.66
0.22
+0.70%
前日終値:
$33.08
開ける：
$33.47
24時間の取引高:
2.02M
Relative Volume:
3.60
時価総額：
$1.60B
収益：
$276.26M
当期純損益:
$16.52M
株価収益率:
102.14
EPS:
0.3078
ネットキャッシュフロー:
$24.75M
1週間 パフォーマンス:
-2.66%
1か月 パフォーマンス:
-15.23%
6か月 パフォーマンス:
+5.36%
1年 パフォーマンス:
-34.45%
1日の値動き範囲:
$30.67
$33.63
1週間の範囲:
$30.67
$34.34
52週間の値動き範囲:
$29.24
$47.74
Vericel Corp Stock (VCEL) Company Profile
Compare VCEL vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
31.44 | 1.68B | 276.26M | 16.52M | 24.75M | 0.3078 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-17 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-08-09 | 開始されました | Canaccord Genuity | Buy |
| 2024-06-20 | 開始されました | TD Cowen | Buy |
| 2024-01-25 | アップグレード | Truist | Hold → Buy |
| 2023-08-08 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-11-09 | ダウングレード | Truist | Buy → Hold |
| 2022-10-14 | 再開されました | Stephens | Overweight |
| 2021-01-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 開始されました | Stephens | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2019-10-09 | 開始されました | H.C. Wainwright | Buy |
| 2019-02-28 | ダウングレード | Needham | Buy → Hold |
| 2018-08-08 | 繰り返されました | Needham | Buy |
| 2018-07-16 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | 開始されました | Leerink Partners | Outperform |
| 2018-03-06 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | 繰り返されました | Needham | Buy |
| 2018-03-05 | 繰り返されました | BTIG Research | Buy |
| 2017-06-21 | 開始されました | BTIG Research | Buy |
| 2017-03-13 | 繰り返されました | Needham | Buy |
| 2016-12-22 | 開始されました | Piper Jaffray | Overweight |
| 2016-11-09 | 繰り返されました | Needham | Buy |
| 2016-04-05 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | アップグレード | Needham | Hold → Buy |
すべてを表示
Vericel Corp (VCEL) 最新ニュース
Vericel (NASDAQ:VCEL) Stock Price Down 4.9%Time to Sell? - MarketBeat
Vericel corp director Hagen sells $486k in shares - Investing.com
Vericel (VCEL) director sells 15,000 shares after option exercise - Stock Titan
Vericel Corporation $VCEL Position Increased by Congress Asset Management Co. - MarketBeat
[144] Vericel Corp SEC Filing - Stock Titan
Vericel Corp ($VCEL) CEO 2025 Pay Revealed - Quiver Quantitative
VCEL Stock Price, Quote & Chart | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
What Makes Vericel Corporation (VCEL) an Investment Bet? - Yahoo Finance
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart
Dilated Cardiomyopathy Market: Rapid Growth & Investment - openPR.com
Bank Watch: Can Vericel Corporation sustain earnings growth2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion By Investing.com - Investing.com Australia
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion - Investing.com South Africa
Leerink reiterates Outperform on Vericel stock, $46 target - Investing.com
FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story - Yahoo Finance
Vericel Corporation (VCEL) Secures FDA Approval for Commercial Manufacturing of MACI - Finviz
Vericel (VCEL) Valuation In Focus After FDA Clears MACI Commercial Manufacturing Capacity - simplywall.st
Vericel (NASDAQ:VCEL) Downgraded by Wall Street Zen to Hold - MarketBeat
Vericel (VCEL) Is Down 9.8% After FDA Clears New MACI Plant – Has The Bull Case Changed? - simplywall.st
Vericel wins FDA approval for MACI production at new facility - Investing.com
Insider Sell: Michael Halpin Sells 10,305 Shares of Vericel Corp (VCEL) - GuruFocus
Vericel wins FDA approval for MACI production at new facility By Investing.com - Investing.com Canada
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com Australia
FDA Greenlights Vericel (VCEL) Facility for MACI Production - GuruFocus
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility - The Manila Times
FDA approves new Vericel cell therapy plant to expand cartilage repair - Stock Titan
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com
Sports injury and burn care firm Vericel heads to investor conferences - Stock Titan
Affiliate sale notice for Vericel (NASDAQ: VCEL) — 15,000 shares listed - Stock Titan
VCEL (NASDAQ: VCEL) Form 144 lists vested share sale entries - Stock Titan
H.C. Wainwright raises Vericel stock price target on revenue growth By Investing.com - Investing.com Canada
William Blair Investment Management LLC Buys 1,048,864 Shares of Vericel Corporation $VCEL - MarketBeat
H.C. Wainwright raises Vericel stock price target on revenue growth - Investing.com
Equities Analysts Offer Predictions for Vericel Q4 Earnings - Defense World
HC Wainwright Boosts Vericel (NASDAQ:VCEL) Price Target to $64.00 - Defense World
A Look At Vericel (VCEL) Valuation After Record 2025 Results And Upbeat 2026 Growth Guidance - Yahoo Finance
Should You Buy Vericel Corp (VCEL) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
VCEL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Vericel (NASDAQ:VCEL) Given New $64.00 Price Target at HC Wainwright - MarketBeat
VCEL Analyst Rating: HC Wainwright & Co. Raises Price Target | V - GuruFocus
Vericel Corporation (NASDAQ:VCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case - ChartMill
Vericel (VCEL) EPS Jump In Q4 2025 Tests Premium 115x P/E Narrative - simplywall.st
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Vericel Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Vericel (NASDAQ:VCEL) Issues Quarterly Earnings Results - MarketBeat
Vericel (VCEL) CEO logs RSU vesting, phantom stock deferral and tax shares - Stock Titan
Vericel (VCEL) CMO logs RSU vesting, phantom stock and tax share withholdings - Stock Titan
RSU vesting boosts Vericel (VCEL) officer Siegal’s shareholding - Stock Titan
Vericel (VCEL) CFO logs RSU vesting and tax withholding share dispositions - Stock Titan
Vericel Corp (VCEL) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):